Table 4 |.
Comparison of experimental off-target site search tools with estimated performance characteristics
| Name | Method | What is detected? | Setting | Cut site enrichment | Cellular false positives |
|---|---|---|---|---|---|
| In vitro | |||||
| Digenome-seq47 | NGS fragment end statistics | DSB | DNA | 170* | 65% |
| CIRCLE-seq49 | DSB end enrichment | DSB | DNA | 821 | 88% |
| SITE-seq48 | DSB end enrichment | DSB | DNA | 178 | 95% |
| DIG-seq51 | NGS fragment end statistics | DSB | Chromatin | 289* | 64% |
| In vivo | |||||
| HTGTS26 | Rearrangement detection | Repair product | Cells | 4,700 | n.d. |
| GUIDE-seq27 | Oligonucleotide integration | Repair product | Cells | 29,000 | 20% |
| DISCOVER-seq55 | DSB end enrichment | DSB | Cells/tissue | 233 | ∼0% |
| BLISS54 | DSB end tagging | DSB | Cells/tissue | 160 | 20% |
Summary of experimental techniques for off-target cutting by programmable nucleases. Because all methods rely on specific enrichment of either DNA close to cut sites or DNA ends close to cut sites, we use the degree to which they achieve enrichment of DNA fragments near the on-target editing site (‘Cut site enrichment’) as a proxy for their sensitivity. For ‘Cellular false positives’, we use the fraction of sites identified by each technique that fail to be edited (indels <0.1%) in the accompanying cellular validation studies; see main text for details.
Cut site enrichment for Digenome-seq and DIG-seq was assessed by enrichment of sequencing fragments whose ends are precisely at the on-target editing site.
n.d., not determined.